Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Concert Pharmaceuticals, Inc. (CNCE)

« Back to company index

CNCE Chatter Timeline

Stock Ticker for CNCE

Most Active Tweeters for CNCE

UserTweets
@Tickeron 7
@TickerReport 3
@WeekHerald 2
@SeekingAlpha 2
@ThisLincolnian 2

Recent Tweets for CNCE

TickerReport @TickerReport
Concert Pharmaceuticals $CNCE Downgraded by ValuEngine https://t.co/FwUnKONzIn
4:09am
TickerReport @TickerReport
Savara $SVRA vs. Concert Pharmaceuticals $CNCE Head-To-Head Contrast https://t.co/Zx0EQbOub8
September 15th 2019, 4:09am
Tickeron @Tickeron
$CNCE in Downtrend: 50-day Moving Average moved below 200-day Moving Average on June 5, 2018. View odds for this an… https://t.co/VryY7iAiiF
September 14th 2019, 6:09am
WeekHerald @WeekHerald
Concert Pharmaceuticals $CNCE Downgraded to Hold at ValuEngine https://t.co/XWHJ0ucFUM
September 13th 2019, 5:09pm
ThisLincolnian @ThisLincolnian
Concert Pharmaceuticals $CNCE Downgraded by ValuEngine https://t.co/FKLpz8jiR5
September 13th 2019, 5:09pm
Tickeron @Tickeron
$CNCE in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/jvYB4l5dLR
September 13th 2019, 3:09am
dakotafinancial @dakotafinancial
Concert Pharmaceuticals $CNCE Downgraded by ValuEngine to “Hold” https://t.co/hu2A7QYqLj
September 13th 2019, 12:09am
SeekingAlpha @SeekingAlpha
$CNCE - Concert Gears Up For Late-Stage Study After Showing It Has The Goods For Treating Hair Loss https://t.co/hQPQQ09GxC
September 12th 2019, 1:09pm
StockNewsNow @StockNewsNow
$CNCE Concert Pharmaceuticals Announces CTP-543 Phase 2 Alopecia Areata Data Selected for Late-Breaker Oral Present… https://t.co/L5vmVynqWT
September 12th 2019, 10:09am
ProVesting @ProVesting
$CNCE: Concert Pharmaceuticals Announces CTP-543 Phase 2 Alopecia …: https://t.co/JINU4ZftJj
September 12th 2019, 7:09am
Tickeron @Tickeron
$CNCE in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/c4QJJkhAqu
September 12th 2019, 4:09am
AmericanBanking @AmericanBanking
Analysts’ Weekly Ratings Changes for Concert Pharmaceuticals $CNCE https://t.co/EmMO4s88hG #stocks
September 11th 2019, 8:09pm
WatchlistN @WatchlistN
Analysts’ Weekly Ratings Changes for Concert Pharmaceuticals $CNCE https://t.co/w0Jlfa7pDB
September 11th 2019, 8:09pm
Tickeron @Tickeron
$CNCE in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/iwa3esFzd6
September 11th 2019, 3:09am
SeekingAlpha @SeekingAlpha
$CNCE - Concert Pharmaceuticals (CNCE) Investor Presentation - Slideshow https://t.co/xVPfs96YW2
September 10th 2019, 12:09pm
Jdalexander64 @Jdalexander64
$CNCE CTP-692 appears to have overcome the safety hurdles of D-serine & D-serine shown to have strong efficacy in s… https://t.co/9pnJ3KNUnh
September 10th 2019, 6:09am
Tickeron @Tickeron
$CNCE in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/PQekXB4bky
September 10th 2019, 3:09am
Mholdify @Mholdify
RT @ConcertPharma: $CNCE will be presenting today at the H.C. Wainwright Conference #HCWCO at 8:45 a.m. ET. Listen here: https://t.co/8BFtm…
September 9th 2019, 8:09am
ConcertPharma @ConcertPharma
$CNCE will be presenting today at the H.C. Wainwright Conference #HCWCO at 8:45 a.m. ET. Listen here:… https://t.co/XqOcCc8RAy
September 9th 2019, 6:09am
TickerReport @TickerReport
Concert Pharmaceuticals $CNCE Upgraded by BidaskClub to Hold https://t.co/FOg3YQ0vu7
September 9th 2019, 4:09am
Tickeron @Tickeron
$CNCE in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/Q1m1BdBc1v
September 9th 2019, 2:09am
dailypoliticaln @dailypoliticaln
Concert Pharmaceuticals Inc $CNCE Receives Average Recommendation of “Buy” from Brokerages https://t.co/DMsZO2AtbZ
September 8th 2019, 9:09pm
ZolmaxNews @ZolmaxNews
Concert Pharmaceuticals Inc $CNCE Receives Average Rating of “Buy” from Brokerages https://t.co/LcA6bArm6q
September 8th 2019, 9:09pm
macondailynews @macondailynews
Concert Pharmaceuticals $CNCE Stock Rating Upgraded by BidaskClub https://t.co/ddNWdJobKx
September 8th 2019, 3:09pm
TheMarketsDaily @TheMarketsDaily
Concert Pharmaceuticals $CNCE Lifted to “Hold” at BidaskClub https://t.co/cjqeI6viCr
September 8th 2019, 3:09pm
ConsumerFeed @ConsumerFeed
Concert Pharmaceuticals $CNCE PT Raised to $29.00 at Mizuho https://t.co/jbsWcEE0Fl
September 8th 2019, 1:09pm
Tickeron @Tickeron
$CNCE in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/LTMowmjsZF
September 8th 2019, 3:09am
TranscriptDaily @TranscriptDaily
Concert Pharmaceuticals $CNCE Upgraded at ValuEngine https://t.co/YTj9ombX9e
September 8th 2019, 2:09am
ThisLincolnian @ThisLincolnian
Concert Pharmaceuticals $CNCE Upgraded at ValuEngine https://t.co/ALilZHZIa6
September 8th 2019, 2:09am
EnterpriseLeade @EnterpriseLeade
Concert Pharmaceuticals $CNCE Upgraded at ValuEngine https://t.co/SiZWUzF542
September 8th 2019, 2:09am
registrarjourn @registrarjourn
Concert Pharmaceuticals $CNCE Upgraded at ValuEngine https://t.co/obvOZmXG5x
September 8th 2019, 2:09am
WeekHerald @WeekHerald
Concert Pharmaceuticals $CNCE Upgraded at ValuEngine https://t.co/kmqK34F3Rl
September 7th 2019, 9:09am
OlympiaReport @OlympiaReport
Mizuho Boosts Concert Pharmaceuticals $CNCE Price Target to $29.00 https://t.co/qDFiAPMI8N
September 7th 2019, 9:09am
stocknewstimes @stocknewstimes
Concert Pharmaceuticals $CNCE Upgraded at Zacks Investment Research https://t.co/KXfN0ldRTp
August 11th 2019, 2:08pm
TranscriptDaily @TranscriptDaily
Concert Pharmaceuticals $CNCE Upgraded at Zacks Investment Research https://t.co/ZTppUwZBgI
August 11th 2019, 2:08pm
dakotafinancial @dakotafinancial
Concert Pharmaceuticals $CNCE Rating Lowered to Hold at ValuEngine https://t.co/ToSBP1X98H
August 11th 2019, 1:08pm
WeekHerald @WeekHerald
Concert Pharmaceuticals $CNCE Stock Rating Lowered by ValuEngine https://t.co/2YX9TsCGFh
August 10th 2019, 7:08pm
ThisLincolnian @ThisLincolnian
Concert Pharmaceuticals $CNCE Stock Rating Lowered by ValuEngine https://t.co/sP7u0YB5JL
August 10th 2019, 7:08pm
dakotafinancial @dakotafinancial
Concert Pharmaceuticals $CNCE Upgraded to “Buy” at Zacks Investment Research https://t.co/oaDto7Llfv
August 10th 2019, 6:08pm
Tickeron @Tickeron
$CNCE's Aroon indicator reaches into Uptrend on August 8, 2019. View odds for this and other indicators:… https://t.co/6NK1IQCOtr
August 10th 2019, 3:08am
dispatchtribune @dispatchtribune
Concert Pharmaceuticals $CNCE Downgraded by ValuEngine to Hold https://t.co/GCLhwBJpNN
August 9th 2019, 6:08pm
registrarjourn @registrarjourn
Concert Pharmaceuticals $CNCE Downgraded by ValuEngine to Hold https://t.co/wYAl4L5wrv
August 9th 2019, 6:08pm
EnterpriseLeade @EnterpriseLeade
Concert Pharmaceuticals $CNCE Downgraded by ValuEngine to Hold https://t.co/a4M8qo8Iw9
August 9th 2019, 6:08pm
OlympiaReport @OlympiaReport
Concert Pharmaceuticals $CNCE Downgraded by ValuEngine to Hold https://t.co/hr2mXd4Uq1
August 9th 2019, 6:08pm
Tickeron @Tickeron
$CNCE's Aroon indicator reaches into Uptrend on August 7, 2019. View odds for this and other indicators:… https://t.co/ycluLUmmD2
August 9th 2019, 2:08am
ZolmaxNews @ZolmaxNews
Zacks Investment Research Upgrades Concert Pharmaceuticals $CNCE to Buy https://t.co/sdSf71PfgH
August 8th 2019, 5:08pm
dailypoliticaln @dailypoliticaln
Concert Pharmaceuticals $CNCE Upgraded by Zacks Investment Research to “Buy” https://t.co/yUsu8ceAJz
August 8th 2019, 5:08pm
bbnsnews @bbnsnews
Concert Pharmaceuticals $CNCE Rating Lowered to Hold at ValuEngine https://t.co/mlEgp6K8iB
August 8th 2019, 10:08am
Tickeron @Tickeron
$CNCE in Downtrend: 50-day Moving Average broke below 200-day Moving Average on June 5, 2018. View odds for this an… https://t.co/bfGnbEHNlG
August 8th 2019, 4:08am
ConsumerFeed @ConsumerFeed
Concert Pharmaceuticals $CNCE Upgraded to “Buy” by Zacks Investment Research https://t.co/4qbzHZDcpO
August 7th 2019, 8:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.